文献速递血栓与止血

免疫性血小板减少症危重出血的定义:ISTH SSC血小板免疫学委员会的通讯

Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
PubMed 文献 · J Thromb Haemost · 2021-01-01

国际血栓与止血学会血小板免疫学SSC认可了ITP危重出血的标准化定义。该定义由ITP应急管理指南专家组基于现有ITP出血评分和抗凝患者大出血定义达成共识,涵盖解剖部位和生理风险两方面,适用于确诊或疑似ITP且通常血小板计数低于20×10^9/L的患者。

要点

  • ITP危重出血定义为关键解剖部位出血或导致血流动力学不稳定/呼吸受损的持续出血。
  • 关键解剖部位包括颅内、椎管内、眼内、腹膜后、心包或伴骨筋膜室综合征的肌内出血。
  • 该定义适用于确诊或疑似ITP且通常血小板计数低于20×10^9/L的患者。

核心结论

  • ITP危重出血定义为关键解剖部位出血或导致血流动力学不稳定或呼吸受损的持续出血。
  • 该定义由ITP应急管理指南专家组制定并获得ISTH血小板免疫学SSC认可。

研究设计与样本

  • 专家组通过面对面和虚拟会议达成共识。
  • 定义参考了现有ITP出血评分和接受抗凝治疗患者的大出血定义。

主要发现

  • 危重ITP出血包括关键解剖部位出血:颅内、椎管内、眼内、腹膜后、心包或伴骨筋膜室综合征的肌内出血。
  • 危重ITP出血也包括导致血流动力学不稳定或呼吸受损的持续出血。

关键数值与推荐

  • 关键解剖部位包括颅内、椎管内、眼内、腹膜后、心包或伴骨筋膜室综合征的肌内出血。
  • 持续出血需导致血流动力学不稳定或呼吸受损。
  • 定义适用于确诊或疑似ITP且通常血小板计数低于20×10^9/L的患者。

临床怎么用

  • 用于识别ITP患者中需紧急处理的危重出血事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immune thrombocytopenia (ITP) is an autoimmune disease characterized by low platelet counts and increased risk of bleeding. In preparation for an upcoming guideline, the ITP Emergency Management Guideline Panel, including clinical experts in hematology, emergency medicine, research methodology, and patient representatives, identified the need for a standardized definition of a critical ITP bleed. The goal of the definition was to distinguish critical bleeds from bleeds that may not require urgent treatment, typically in the context of severe thrombocytopenia. METHODS: The panel met in person and virtually to achieve consensus on the criteria for critical bleeding events among patients with ITP. Existing ITP bleeding scores and published definitions of major bleeds in patients receiving anticoagulation informed the definition of a critical ITP bleed. The Platelet Immunology Scientific Standardization Committee (SSC) of the International Society on Thrombosis and Haemostasis endorsed the definition. RESULTS: A critical ITP bleed was defined as: (a) a bleed in a critical anatomical site including intracranial, intraspinal, intraocular, retroperitoneal, pericardial, or intramuscular with compartment syndrome; or (2) an ongoing bleed that results in hemodynamic instability or respiratory compromise. CONCLUSION: The definition of a critical ITP bleed was developed by the ITP Emergency Management Guideline Panel and endorsed by the Platelet Immunology SSC. It incorporates both anatomic and physiologic risk and pertains to patients with confirmed or suspected ITP who typically have severe thrombocytopenia (platelet count below 20 × 109 /L).

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Sirotich E, Guyatt G, Gabe C, et al. Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost. 2021. PMID: 34327824. doi:10.1111/jth.15368

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。